Coronavirus delayed and digitalized Orifarm's billion-kroner deal
The covid-19 outbreak meant negotiators for Orifarm and Takeda were forced to adapt - and complete a historic deal without meeting one another in person.
BY ULRICH QUISTGAARD, TRANSLATED BY CATHERINE BRETT
Tentative steps towards the billion-kroner deal between Orifarm and Takeda were being taken last summer, but just as the actual negotiations were due to start, the coronavirus outbreak made its mark on the world - and on the two companies' attempts to negotiate.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
